MedTrace Logo

Magnesium Sulfate Versus Placebo for Tocolysis in PPROM

NCT00463736 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2016-08-19

No results posted yet for this study

Summary

Study compares the outcomes of women between 26 and 32 wks gestation with rupture of membranes. Women randomized to receive tocolysis with magnesium sulfate x 48 hrs or placebo of saline IV x 48 hrs. Antibiotics and antenatal steroids given to both groups.

Conditions

  • Preterm Premature Rupture of Membranes

Interventions

DRUG

Magnesium sulfate

Sponsors & Collaborators

  • Regional Obstetrical Consultants

    lead OTHER

Principal Investigators

  • Christian M Briery, MD · Regional Obstetrical Consultants; UT Chattanooga OB-GYN Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00463736 on ClinicalTrials.gov